The purpose of this study was to estimate the economic burden of brain disorder and provide relevant information to support health policy for people with brain disorder in Korea.
Methods
The economic burden of brain disorder in Korea was estimated on the basis of direct and indirect costs using a prevalence-based approach. Data were retrieved from the nationwide databases between 2008 and 2011: Korea National Health Insurance Corporation, the National Disability Registry of Ministry of Health and Welfare, the Korea National Statistical Offices' records of cause of death. The direct costs were those that result from primary medical and non medical expenses directly associated with brain disorder such as caregiver costs, and transportation costs. The indirect costs referred to costs of lost opportunity due to premature death and productivity loss and a 3% discount rate was applied for the calculation. 
